Biopolymers codelivering engineered T cells and STING agonists can eliminate heterogeneous tumors
Tyrel T. Smith(Fred Hutch Cancer Center), Matthias T. Stephan(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa)
Cited by 332
Related Papers
Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers
|Nature Communications|2019|498